DAY ONE BIOPHARMACEUTICALS, INC.: cashflow_financing
| Value | {"amount": 1184000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-03-31 |
| Status | current |
| Entity | DAY ONE BIOPHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:35:10.395833+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0f6a6200-51fc-46b5-8436-8a881c2cd523
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-016046Retrieved: 2026-08-19T18:35:10.395833+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001845337/cashflow-financing/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0f6a6200-51fc-46b5-8436-8a881c2cd523
History
- no predecessors — first report